Montana Unveils Ambitious Initiative to Revolutionize Medical AI Research

As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once

Related Stories

India's Vending Machine Future: From Snacks to Smart Gadgets

Fadnavis Forecasts India's Dominance in AI, Semiconductors, and Quantum Computing This Century

India's Rare Book Heritage at Risk as AI-Driven Destruction Gathers Pace Locally

📰

India Edges Closer to Regulating AI-Enhanced Pharmacological Experiments